The Scientist

» research misconduct and disease/medicine

Most Recent

image: Contributors

Contributors

By | January 1, 2017

Meet some of the people featured in the January 2017 issue of The Scientist.

0 Comments

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Karolinska Finds Macchiarini Guilty of Misconduct

Karolinska Finds Macchiarini Guilty of Misconduct

By | December 22, 2016

The embattled thoracic surgeon is dealt another blow by his former employer, which is calling for the retraction of one of his papers on artificial esophagus research.

0 Comments

image: Top 10 Retractions of 2016

Top 10 Retractions of 2016

By | December 21, 2016

A look at this year’s most memorable retractions

2 Comments

image: Opinion: The Scientist’s Scarlet Letter

Opinion: The Scientist’s Scarlet Letter

By | December 16, 2016

Managing privacy protections and expectations in a misconduct proceeding

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

Lawyers involved discuss the latest twist in the ongoing litigation that pits pathologist Fazlul Sarkar against anonymous commenters on the post-publication peer review site.

1 Comment

Court of Appeals denies a motion filed by ACLU lawyers to enter the full Wayne State University investigation of pathologist Fazlul Sarkar into the official case record.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS